Consumer advertising of psychiatric medications biases the public against nonpharmacological treatment
{{output}}
In the United States, antidepressant medications are heavily promoted through direct-to-consumer advertising, which is regulated by the Food and Drug Administration (FDA). Advertisements for selective serotonin reuptake inhibitors frequently contain informatio... ...
